![Nicolas Leupin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicolas Leupin
Plus aucun poste en cours
Fortune : 2 M $ au 31/07/2026
Profil
Nicolas Leupin worked as Chief Medical Officer at argenx SE from 2016 to 2019 and at Molecular Partners AG from 2019 to 2023.
Also held the position of Chief Medical Officer at NovoCure Ltd. and was a Member of the Swiss Group for Clinical Research.
Education includes a doctorate from the University of Bern and an MBA from Jones International University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NOVOCURE LTD. 0,09% | 06/04/2026 | 102 979 ( 0,09% ) | 2 M $ | 31/07/2026 |
Anciens postes connus de Nicolas Leupin
| Sociétés | Poste | Fin |
|---|---|---|
| MOLECULAR PARTNERS AG | Directeur Technique/Scientifique/R&D | 24/08/2023 |
| ARGENX SE | Directeur Technique/Scientifique/R&D | 01/07/2019 |
| NOVOCURE LIMITED | Directeur Technique/Scientifique/R&D | - |
Swiss Group for Clinical Research | Corporate Officer/Principal | - |
Formation de Nicolas Leupin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
28
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Jones International University
 Jones International University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Bern
 University of Bern Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Partners AG
 Molecular Partners AG BiotechnologyHealth Technology Engages in discovery, development and commercialization of biopharmaceutical products | Health Technology |
NovoCure Ltd.
 NovoCure Ltd. Medical SpecialtiesHealth Technology Operates as a commercial-stage oncology company | Health Technology |
argenx SE
 argenx SE BiotechnologyHealth Technology Develops therapies and medicines for the treatment of autoimmune diseases | Health Technology |
Swiss Group for Clinical Research |
